Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmunity seen through the SEREX-scope.

Philippe Krebs1, Michael Kurrer, Ugur Sahin

  • 1Institute of Experimental Immunology, Department of Pathology, University Hospital Zürich, CH-8091 Zürich, Switzerland.

Autoimmunity Reviews
|October 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PMGen: from peptide-MHC structure prediction to peptide generation.

Bioinformatics (Oxford, England)·2026
Same author

Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trial.

The Lancet. Infectious diseases·2026
Same author

Targeting the miR-19b/PPP2R5E axis enhances temozolomide response in glioblastoma via ROS-induced DNA damage.

British journal of cancer·2026
Same author

The roles and diversity of alarmins in the mucosae.

Advances in immunology·2026
Same author

IL-33-induced ILC2 effector cytokine responses promote the expansion of red pulp macrophages.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

A Study to Investigate the Safety and Immunogenicity of Monovalent Omicron LP.8.1-Adapted BNT162b2 COVID-19 Vaccine in Adults ≥ 65 Years of Age and High-Risk Adults 18-64 Years of Age (Preliminary Results).

Vaccines·2026

Autoantibodies signal early autoimmune disease activity and can be identified using potent screening methods. The SEREX method, initially for cancer, shows promise for analyzing autoimmune disease immune responses.

Area of Science:

  • Immunology
  • Autoimmunity
  • Molecular Biology

Background:

  • Autoimmune diseases often have long prodromal phases.
  • Autoantibodies can serve as early indicators of disease activity.
  • Identifying target antigens is crucial for understanding autoimmune diseases.

Purpose of the Study:

  • To explore the utility of autoantibody-based screening methods.
  • To investigate the application of the SEREX method in autoimmune diseases.
  • To analyze complex immune responses in autoimmunity.

Main Methods:

  • Utilizing autoantibody detection for early disease indicators.
  • Applying the SEREX (serological identification of antigens by recombinant expression cloning) method.
  • Analyzing complex immune responses in autoimmune conditions.

Related Experiment Videos

Main Results:

  • Autoantibodies are detectable in early stages of autoimmune diseases.
  • The SEREX method, developed for tumor antigens, is applicable to autoimmune research.
  • SEREX facilitates the analysis of immune responses in autoimmune diseases.

Conclusions:

  • Autoantibody screening is valuable for early detection and antigen identification in autoimmune diseases.
  • The SEREX approach offers a novel tool for studying immune responses in autoimmunity.
  • Further research can leverage SEREX for a deeper understanding of autoimmune pathogenesis.